Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban for Scheduled Work-up of Patients With Suspected Deep Venous Thrombosis

NCT02486445 is registered in ClinicalTrials.gov with Ostfold Hospital Trust as lead sponsor.

NCT NCT02486445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02486445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban for Scheduled Work-up of Patients With Suspected Deep Venous Thrombosis
Lead sponsor
Ostfold Hospital Trust
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2015
Completion date
December 30, 2018
Enrollment
625 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep venous thrombosis